Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Privacy Policy  
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english espańol polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
Cabergoline to shorten interestrous intervals in dogs
Cabergoline is used in canine medicine for a few years. Is it also possible to shorten interestreous intervals in dogs which is desirable especially in breeding dogs? A study in 23 dogs shows: The mean number of days of cabergoline treatment until the onset of proestrus was 21.4Ā±2.9!

Two consecutive interestrous intervals (n=46) were recorded in 23 bitches of different breeds.

At varying times after day 100 from the onset of the second proestrus, cabergoline (5 Āµg/kg per os q 24 hours) was administered from early (n=11), mid- (n=10), and late (n=2) anestrus until 2 days after the beginning of the following proestrus.

Interestrous intervals (IEI) were significantly shorter in the cabergoline-treated time periods when compared to the nontreated IEI (184Ā±4.5 days versus 239Ā±4.5 days; P<0.01). The mean number of days of cabergoline treatment until the onset of proestrus was 21.4Ā±2.9 (least square means and standard error of the mean [LSMĀ±SEM]).

Mean cabergoline treatment durations beginning in early, mid-, and late anestrus were 27.4Ā±3.7, 17.6Ā±3.8, and 5Ā±3 days (LSMĀ±SEM), respectively.

A significant correlation was found between the stage of anestrus in which the treatments began and the duration of the treatments required to induce estrus (0.51, P=0.01).

Source: Cristina Gobello, Gervasio Castex, Luzbel Dela sota, Yanina Corrada (2004): Shortening of Interestrous Intervals With Cabergoline in Bitches: A Clinical Trial. In: Journal of the American Animal Hospital Association 40:115-119 (2004)




Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

Vocal fold granulomas in brachycephalic dogsmembers
Vocal cord granulomas are rarely observed in brachycephalic breeds but often reported in humans as contact granulomas. Six French bulldogs were included in this retrospective descriptive study. A very informative new study adding new Information to the brachycephalic airway Syndrome.

  • Extracellular vesicles in mammary cancer of dogs and catsmembers
  • Immunocytochemical assay using aqueous humor to diagnose feline infectious peritonitis members
  • Microbiota of traumatic, open fracture wounds and the mechanism of injury members
  • False-positive CT and radiography results for bronchial collapse in healthy dogsmembers
  • Variability of SDMA in apparently healthy dogsmembers
  • Bioavailability of suppository acetaminophen in dogsmembers
  • Computed tomographic Ālymphography for lymph node staging in dogs with malignant tumors members
  • Characterization of ocular melanosis-affected canine melanocytesmembers
  • Nasopharyngeal sialoceles in brachycephalic dogsmembers
  • Enterococcus faecium SF68 on serum cobalamin and folate concentrationsmembers
  • Gastrointestinal eosinophilic sclerosing fibroplasia limited to the mesentery in a catmembers
  • Ion acid-base disturbances and associated mortality in dogsmembers


  • [ Home ] [ About ] [ Contact / Request ] [ Privacy Policy ]

    Copyright © 2001-2018 VetContact GmbH
    All rights reserved